港股異動 | 新特能源(1799.HK)暴跌超20% 擬發行不超1.77億股內資股
格隆匯4月30日丨新特能源(1799.HK)計劃發行內資股,股價應聲下瀉,今早大幅低開約11.5%,現跌幅擴大至逾20%,報17.56港元,最新總市值211億港元。新特能源公佈發行內資股,涉及不超過1.77億股,佔最終擴大股本約12.9%,控股股東特變電工有意認購不多於1.67億股。新特能源稱,內資股發行資金,將分別通過向內蒙古新特及新疆新能源增資方式使用,用於建設10萬噸多晶硅項目及補充風電及光伏資源開發的營運資金。交易完成後,特變電工及其聯繫人持股會由65.43%,增至69.15%,H股公眾股東則由原先26.02%,攤薄至22.67%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.